These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10391187)

  • 1. Monoclonal antibodies against respiratory syncytial virus.
    Givner LB
    Pediatr Infect Dis J; 1999 Jun; 18(6):541-2. PubMed ID: 10391187
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing respiratory syncytial virus (RSV) disease in children.
    Karron RA
    Science; 2021 May; 372(6543):686-687. PubMed ID: 33986169
    [No Abstract]   [Full Text] [Related]  

  • 3. Respiratory syncytial virus: babies and antibodies.
    Hemming VG; Prince GA
    Infect Agents Dis; 1992 Feb; 1(1):24-32. PubMed ID: 1365525
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-respiratory syncytial virus monoclonal antibodies show promise in the treatment and prophylaxis of viral disease.
    Taylor G; Porter T; Dillon S; Trill J; Ganguly S; Hart T; Davis C; Wyde P; Tempest P; Harris W
    Biochem Soc Trans; 1995 Nov; 23(4):1063-7. PubMed ID: 8654682
    [No Abstract]   [Full Text] [Related]  

  • 5. Respiratory syncytial virus (RSV) as a common cause of respiratory illness in children younger than 5 years.
    Poehling KA; Hickson GB
    Ambul Pediatr; 2003; 3(6):342-4. PubMed ID: 14616052
    [No Abstract]   [Full Text] [Related]  

  • 6. Respiratory syncytial virus: concerns and control.
    McCarthy CA; Hall CB
    Pediatr Rev; 2003 Sep; 24(9):301-9. PubMed ID: 12949266
    [No Abstract]   [Full Text] [Related]  

  • 7. Passive immunization for the prevention of otitis media.
    Englund JA; Glezen WP
    Vaccine; 2000 Dec; 19 Suppl 1():S116-21. PubMed ID: 11163474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Respiratory Syncytial Virus Infection: From Vaccine to Antibody.
    Huang K; Wu H
    Microbiol Spectr; 2014 Aug; 2(4):AID-0014-2014. PubMed ID: 26104207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of respiratory syncytial virus infection.
    Kimpen JL
    Curr Opin Infect Dis; 2001 Jun; 14(3):323-8. PubMed ID: 11964851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    Meissner HC; Long SS;
    Pediatrics; 2003 Dec; 112(6 Pt 1):1447-52. PubMed ID: 14654628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus vaccine development.
    Kahn JS
    Curr Opin Pediatr; 2000 Jun; 12(3):257-62. PubMed ID: 10836163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus: different criteria for palivizumab use in different areas?
    Mitchell I
    South Med J; 2007 Jul; 100(7):661-2. PubMed ID: 17639741
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus.
    Meissner HC; Bocchini JA; Brady MT; Hall CB; Kimberlin DW; Pickering LK
    Pediatrics; 2009 Dec; 124(6):1676-9. PubMed ID: 19948632
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Levin MJ; Hall CB; Long CE; Rodriguez WJ; Arrobio J; Meissner HC; Fulton DR; Welliver RC
    N Engl J Med; 1993 Nov; 329(21):1524-30. PubMed ID: 8413475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The race to make vaccines for a dangerous respiratory virus.
    Powell K
    Nature; 2021 Dec; 600(7889):379-380. PubMed ID: 34893769
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience of palivizumab in prophylaxis of respiratory syncytial viral infection in premature children with bronchopulmonary dysplasia].
    Aliamovskaia GA; Keshinian ES
    Vestn Ross Akad Med Nauk; 2012; (12):30, 32-4. PubMed ID: 23530423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations for immunologic prevention of respiratory syncytial virus (RSV) infections].
    Z Geburtshilfe Neonatol; 1999 Dec; 203 Suppl 2():16. PubMed ID: 10612193
    [No Abstract]   [Full Text] [Related]  

  • 18. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
    Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation.
    Cortez K; Murphy BR; Almeida KN; Beeler J; Levandowski RA; Gill VJ; Childs RW; Barrett AJ; Smolskis M; Bennett JE
    J Infect Dis; 2002 Sep; 186(6):834-8. PubMed ID: 12198619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in prevention of respiratory syncytial virus infections.
    Prober CG; Sullender WM
    J Pediatr; 1999 Nov; 135(5):546-58. PubMed ID: 10547241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.